Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Pathogenesis of triple-negative breast cancer
Triple-negative breast cancer (TNBC) encompasses a heterogeneous group of
fundamentally different diseases with different histologic, genomic, and immunologic …
fundamentally different diseases with different histologic, genomic, and immunologic …
[HTML][HTML] Pyroptosis: a new frontier in cancer
Pyroptosis is an inflammatory form of cell death triggered by certain inflammasomes, leading
to the cleavage of gasdermin D (GSDMD) and activation of inactive cytokines like IL-18 and …
to the cleavage of gasdermin D (GSDMD) and activation of inactive cytokines like IL-18 and …
Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin
Triple-negative breast cancer (TNBC) is an aggressive subtype associated with early
metastatic recurrence and worse patient outcomes. TNBC tumors express molecular …
metastatic recurrence and worse patient outcomes. TNBC tumors express molecular …
Targeting apoptosis in cancer
Abstract Purpose of Review Apoptosis is a major mechanism of cancer cell death. Thus,
evasion of apoptosis results in therapy resistance. Here, we review apoptosis modulators in …
evasion of apoptosis results in therapy resistance. Here, we review apoptosis modulators in …
Pathology of triple negative breast cancer
F Borri, A Granaglia - Seminars in cancer biology, 2021 - Elsevier
Triple negative breast cancer (TNBC) is a subtype of breast tumor lacking hormone
receptors expression and HER2 gene amplification and represents 24% of newly diagnosed …
receptors expression and HER2 gene amplification and represents 24% of newly diagnosed …
Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence
Triple-negative breast cancer (TNBC) is a kind of breast cancer that lacks estrogen,
progesterone, and human epidermal growth factor receptor 2. This cancer is responsible for …
progesterone, and human epidermal growth factor receptor 2. This cancer is responsible for …
An overview of triple-negative breast cancer
Purpose Triple-negative breast cancer (TNBC) is a heterogeneous group of tumors
comprising various breast cancers simply defined by the absence of estrogen receptor …
comprising various breast cancers simply defined by the absence of estrogen receptor …
Triple-negative breast cancer: treatment challenges and solutions
J Collignon, L Lousberg, H Schroeder… - Breast Cancer: Targets …, 2016 - Taylor & Francis
Triple-negative breast cancers (TNBCs) are defined by the absence of estrogen and
progesterone receptors and the absence of HER2 overexpression. These cancers represent …
progesterone receptors and the absence of HER2 overexpression. These cancers represent …
[HTML][HTML] Recent therapeutic trends and promising targets in triple negative breast cancer
Breast cancer accounts for 25% of all types of cancer in women, and triple negative breast
cancer (TNBC) comprises around 15~ 20% of breast cancers. Conventional chemotherapy …
cancer (TNBC) comprises around 15~ 20% of breast cancers. Conventional chemotherapy …
Proteomic profiling of extracellular vesicles allows for human breast cancer subty**
Extracellular vesicles (EVs) are a potential source of disease-associated biomarkers for
diagnosis. In breast cancer, comprehensive analyses of EVs could yield robust and reliable …
diagnosis. In breast cancer, comprehensive analyses of EVs could yield robust and reliable …